- Works count
- 587
- Citation count
- 37,010
- H-index
- 72
- i10-index
- 204
Research interests
Publications
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac237
ERS statement on chronic thromboembolic pulmonary hypertension
European Respiratory Journal · 2020 · https://doi.org/10.1183/13993003.02828-2020
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz405
RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
The Lancet Respiratory Medicine · 2017 · https://doi.org/10.1016/s2213-2600(17)30305-3
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
European Respiratory Journal · 2017 · https://doi.org/10.1183/13993003.00740-2017
Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature
European Respiratory Journal · 2017 · https://doi.org/10.1183/13993003.01792-2016
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1213917
Updated Clinical Classification of Pulmonary Hypertension
Journal of the American College of Cardiology · 2009 · https://doi.org/10.1016/j.jacc.2009.04.012
Prostanoid therapy for pulmonary arterial hypertension
Journal of the American College of Cardiology · 2004 · https://doi.org/10.1016/j.jacc.2004.02.036
Inhaled Iloprost for Severe Pulmonary Hypertension
New England Journal of Medicine · 2002 · https://doi.org/10.1056/nejmoa020204
Current projects
No projects listed.